Literature DB >> 31177526

2- and N6-functionalized adenosine-5'-diphosphate analogs for the inhibition of mortalin.

Mitchell A Moseng1, Jay C Nix2, Richard C Page1.   

Abstract

Our early efforts to find a covalent inhibitor of mortalin, a member of the 70 kD heat shock protein (Hsp70) family, led us to solve the structure of the mortalin nucleotide-binding domain (NBD) in complex with N6-propargyladenosine-5'-diphosphate. The acquired structure emphasizes the ability of the nucleotide-binding pocket to accommodate modified ADP compounds. A library of ADP analogs modified at either the 2- or N6-positions of adenosine was screened against the mortalin-NBD. Competitive inhibition and binding assays of the analogs demonstrate that modifications at the 2- or N6-positions have potential to bind and inhibit mortalin uniquely compared to other Hsp70 homologs, and that modifications at the 2-position confer the greatest selectivity in binding and inhibition of the mortalin-NBD.
© 2019 Federation of European Biochemical Societies.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31177526      PMCID: PMC6690775          DOI: 10.1002/1873-3468.13475

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  36 in total

1.  A phase I and pharmacokinetic study of the mitochondrial-specific rhodacyanine dye analog MKT 077.

Authors:  C D Britten; E K Rowinsky; S D Baker; G R Weiss; L Smith; J Stephenson; M Rothenberg; L Smetzer; J Cramer; W Collins; D D Von Hoff; S G Eckhardt
Journal:  Clin Cancer Res       Date:  2000-01       Impact factor: 12.531

2.  Regulated interactions of mtHsp70 with Tim44 at the translocon in the mitochondrial inner membrane.

Authors:  Patrick D'Silva; Qinglian Liu; William Walter; Elizabeth A Craig
Journal:  Nat Struct Mol Biol       Date:  2004-10-17       Impact factor: 15.369

3.  Mortalin/GRP75 promotes release of membrane vesicles from immune attacked cells and protection from complement-mediated lysis.

Authors:  David Pilzer; Zvi Fishelson
Journal:  Int Immunol       Date:  2005-08-09       Impact factor: 4.823

Review 4.  An Hsp70 family chaperone, mortalin/mthsp70/PBP74/Grp75: what, when, and where?

Authors:  Renu Wadhwa; Kazunari Taira; Sunil C Kaul
Journal:  Cell Stress Chaperones       Date:  2002-07       Impact factor: 3.667

5.  Selective toxicity of MKT-077 to cancer cells is mediated by its binding to the hsp70 family protein mot-2 and reactivation of p53 function.

Authors:  R Wadhwa; T Sugihara; A Yoshida; H Nomura; R R Reddel; R Simpson; H Maruta; S C Kaul
Journal:  Cancer Res       Date:  2000-12-15       Impact factor: 12.701

6.  NIH 3T3 cells malignantly transformed by mot-2 show inactivation and cytoplasmic sequestration of the p53 protein.

Authors:  R Wadhwa; S Takano; Y Mitsui; S C Kaul
Journal:  Cell Res       Date:  1999-12       Impact factor: 25.617

7.  Phase I trial of the selective mitochondrial toxin MKT077 in chemo-resistant solid tumours.

Authors:  D J Propper; J P Braybrooke; D J Taylor; R Lodi; P Styles; J A Cramer; W C Collins; N C Levitt; D C Talbot; T S Ganesan; A L Harris
Journal:  Ann Oncol       Date:  1999-08       Impact factor: 32.976

8.  Activation of wild type p53 function by its mortalin-binding, cytoplasmically localizing carboxyl terminus peptides.

Authors:  Sunil C Kaul; Satoshi Aida; Tomoko Yaguchi; Kamaljit Kaur; Renu Wadhwa
Journal:  J Biol Chem       Date:  2005-09-21       Impact factor: 5.157

9.  Upregulation of mortalin/mthsp70/Grp75 contributes to human carcinogenesis.

Authors:  Renu Wadhwa; Syuichi Takano; Kamaljit Kaur; Custer C Deocaris; Olivia M Pereira-Smith; Roger R Reddel; Sunil C Kaul
Journal:  Int J Cancer       Date:  2006-06-15       Impact factor: 7.396

Review 10.  Hsp70 chaperones: cellular functions and molecular mechanism.

Authors:  M P Mayer; B Bukau
Journal:  Cell Mol Life Sci       Date:  2005-03       Impact factor: 9.261

View more
  2 in total

1.  Neutral analogs of the heat shock protein 70 (Hsp70) inhibitor, JG-98.

Authors:  Hao Shao; Jason E Gestwicki
Journal:  Bioorg Med Chem Lett       Date:  2020-01-11       Impact factor: 2.823

Review 2.  Abrogating the Interaction Between p53 and Mortalin (Grp75/HSPA9/mtHsp70) for Cancer Therapy: The Story so far.

Authors:  Ahmed Elwakeel
Journal:  Front Cell Dev Biol       Date:  2022-04-14
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.